ASMB (Assembly Biosciences) Cyclically Adjusted PB Ratio: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASMB Assembly Biosciences Inc ASMB
32 GF Score
Price $31.82
! 3 Warning Signs
View Full Analysis

What is Assembly Biosciences Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Assembly Biosciences  (NAS:ASMB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Assembly Biosciences Cyclically Adjusted PB Ratio Related Terms


Assembly Biosciences Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Assembly Biosciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assembly Biosciences Cyclically Adjusted PB Ratio Chart

Assembly Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.19 0.13 0.23 0.56

Assembly Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.40 0.56 0.47 0.00

ASMB vs ZURA, ARVN, ARTV: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Assembly Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assembly Biosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Assembly Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Assembly Biosciences's Cyclically Adjusted PB Ratio falls into.


ASMB
32GF Score
Assembly Biosciences Inc ASMB
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Assembly Biosciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Assembly Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Assembly Biosciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=16.211/333.9520*333.9520
=16.211

Current CPI (Jun. 2026) = 333.9520.

Assembly Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201609 62.749 241.428 86.797
201612 55.587 241.432 76.889
201703 47.046 243.801 64.442
201706 39.070 244.955 53.265
201709 32.528 246.819 44.011
201712 67.414 246.524 91.322
201803 60.260 249.554 80.640
201806 51.863 251.989 68.732
201809 108.121 252.439 143.033
201812 99.131 251.233 131.770
201903 89.432 254.202 117.489
201906 81.753 256.143 106.587
201909 72.583 256.759 94.405
201912 100.707 256.974 130.874
202003 92.596 258.115 119.802
202006 97.701 257.797 126.563
202009 98.597 260.280 126.505
202012 84.830 260.474 108.760
202103 73.981 264.877 93.274
202106 63.540 271.696 78.099
202109 57.264 274.310 69.715
202112 42.127 278.802 50.460
202203 36.597 287.504 42.509
202206 30.764 296.311 34.672
202209 25.348 296.808 28.520
202212 20.286 296.797 22.826
202303 16.224 301.836 17.950
202306 12.571 305.109 13.759
202309 9.513 307.789 10.322
202312 7.495 306.746 8.160
202403 5.946 312.332 6.358
202406 5.465 314.175 5.809
202409 4.092 315.301 4.334
202412 4.474 315.605 4.734
202503 3.561 319.799 3.719
202506 2.359 322.561 2.442
202509 11.551 324.800 11.876
202512 13.040 324.054 13.438
202603 12.497 330.213 12.639
202606 16.211 333.952 16.211

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Assembly Biosciences Business Description

Other Exchanges V7B:Germany
Address Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
32GF Score

Get the complete analysis for ASMB

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.82
Price